These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 8413755

  • 1. [Cerebellar atrophy and phenytoin poisoning. An MR study].
    Luef G, Marosi M, Felber S, Birbamer G, Aichner F, Bauer G.
    Nervenarzt; 1993 Aug; 64(8):548-51. PubMed ID: 8413755
    [Abstract] [Full Text] [Related]

  • 2. Cerebellar atrophy following phenytoin intoxication.
    Lindvall O, Nilsson B.
    Ann Neurol; 1984 Aug; 16(2):258-60. PubMed ID: 6476798
    [Abstract] [Full Text] [Related]

  • 3. Phenytoin overdosage and cerebellar atrophy in epileptic patients: clinical and MRI findings.
    Luef G, Chemelli A, Birbamer G, Aichner F, Bauer G.
    Eur Neurol; 1994 Aug; 34 Suppl 1():79-81. PubMed ID: 8001616
    [Abstract] [Full Text] [Related]

  • 4. Cerebellar volume and long-term use of phenytoin.
    De Marcos FA, Ghizoni E, Kobayashi E, Li LM, Cendes F.
    Seizure; 2003 Jul; 12(5):312-5. PubMed ID: 12810345
    [Abstract] [Full Text] [Related]

  • 5. Cerebellar atrophy in an epileptic child: is it due to phenytoin?
    Ahuja SR, Karande S, Kulkarni MV.
    J Postgrad Med; 2000 Jul; 46(4):278-9. PubMed ID: 11435657
    [Abstract] [Full Text] [Related]

  • 6. [Temporal cerebellar atrophy following phenytoin therapy].
    Guerrero AL, Paniagua JA, Díaz Cascajo P, Cacho J, Arias P, Martín JA.
    Neurologia; 1997 Jul; 12(6):259-61. PubMed ID: 9303595
    [Abstract] [Full Text] [Related]

  • 7. [Cerebellar atrophy in epileptic patients: computer tomography study].
    Kessler C, Henningsen H, Reuther R, Christian W.
    Fortschr Neurol Psychiatr; 1985 Dec; 53(12):437-41. PubMed ID: 4077007
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance volumetry of the cerebellum in epileptic patients after phenytoin overdosages.
    Luef G, Burtscher J, Kremser C, Birbamer G, Aichner F, Bauer G, Felber S.
    Eur Neurol; 1996 Dec; 36(5):273-7. PubMed ID: 8864707
    [Abstract] [Full Text] [Related]

  • 9. [Dose-dependent relationship of chronic use of phenytoin and cerebellar atrophy in patients with epilepsy].
    Del Negro A, Dantas CD, Zanardi V, Montenegro MA, Cendes F.
    Arq Neuropsiquiatr; 2000 Jun; 58(2A):276-81. PubMed ID: 10849627
    [Abstract] [Full Text] [Related]

  • 10. [Folic-acid deficiency due to long-term anticonvulsant therapy as a causal factor of cerebellar degeneration (author's transl)].
    Meyer-Wahl L.
    Nervenarzt; 1980 Oct; 51(10):619-22. PubMed ID: 6779215
    [No Abstract] [Full Text] [Related]

  • 11. [Phenytoin poisoning in a degradation disorder, report of a case with cerebellar atrophy].
    Feuerstein T, von Reutern GM, Cramer H.
    Nervenarzt; 1983 Feb; 54(2):106-9. PubMed ID: 6405292
    [No Abstract] [Full Text] [Related]

  • 12. Cerebellar volumes in newly diagnosed and chronic epilepsy.
    Hagemann G, Lemieux L, Free SL, Krakow K, Everitt AD, Kendall BE, Stevens JM, Shorvon SD.
    J Neurol; 2002 Dec; 249(12):1651-8. PubMed ID: 12529786
    [Abstract] [Full Text] [Related]

  • 13. [Plasma separation in acute, intravenous phenytoin poisoning].
    Scharf J, Ruder H, Harms D.
    Monatsschr Kinderheilkd; 1990 Apr; 138(4):227-30. PubMed ID: 2113180
    [Abstract] [Full Text] [Related]

  • 14. [Cerebellar atrophy and persistent cerebellar ataxia after acute intoxication of phenytoin].
    Imamura T, Ejima A, Sahara M, Saito H, Tsuburaya K.
    No To Shinkei; 1992 Feb; 44(2):149-53. PubMed ID: 1567734
    [Abstract] [Full Text] [Related]

  • 15. Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration.
    Tedeschi G, Bertolino A, Massaquoi SG, Campbell G, Patronas NJ, Bonavita S, Barnett AS, Alger JR, Hallett M.
    Ann Neurol; 1996 Jan; 39(1):71-8. PubMed ID: 8572670
    [Abstract] [Full Text] [Related]

  • 16. [Diphenylhydantoin intoxication following the exchange of seemingly equal DPH-preparations (author's transl)].
    Klingler D, Nitsche V, Schmidbauer H.
    Wien Med Wochenschr; 1981 Jan; 131(11):295-300. PubMed ID: 6789561
    [Abstract] [Full Text] [Related]

  • 17. Cerebellar atrophy does not increase susceptibility to carbamazepine toxicity.
    Specht U, Rohde M, May T, Schmidt RC, Meencke HJ, Wolf P.
    Acta Neurol Scand; 1994 Jan; 89(1):1-4. PubMed ID: 8178620
    [Abstract] [Full Text] [Related]

  • 18. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R, Foresti S, Tessa C, Moretti M, Ginestroni A, Gavazzi C, Guerrini L, Salvi F, Piacentini S, Mascalchi M.
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [Abstract] [Full Text] [Related]

  • 19. [Clinical significance of serum phenytoin level].
    Oettinger B, Richter K.
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jul; 30(7):424-9. PubMed ID: 100799
    [Abstract] [Full Text] [Related]

  • 20. [Single daily dose of diphenylhydantoin in treating epilepsy].
    Shen DL.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):145-7. PubMed ID: 3932025
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.